Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Has a corner been turned?
Gross profit in Q2 2024 increased to $263 thousand, or 10% of revenue,
compared to a gross loss of $50 thousand or (-2%) of revenue in Q2 2023.
Press Release: Else Nutrition Reports 2024 Second Quarter Financial Results and Provides Business Update
7:00 AM ET 8/14/24 | Dow Jones
Else Nutrition Reports 2024 Second Quarter Financial Results and Provides Business Update
Canada NewsWire
VANCOUVER, BC, Aug. 14, 2024
Q2 2024 revenue increased 23% to $2.6 million over Q1 2024
Q2 2024 retail sales increased 88% and 111% over Q1 2024 in the U.S. and Canada, respectively
Conference call to be held today at 10:00 AM Eastern Time
VANCOUVER, BC, Aug. 14, 2024 /CNW/ - ELSE NUTRITION HOLDINGS INC. (TSX: BABY) (OTCQX: BABYF) (FSE: 0YL.F) ("Else" or the "Company"), today reported financial results for the second quarter ended June 30, 2024. The financial statements and MD&A are available on SEDAR under the Company's profile.
"We are rapidly expanding our market presence," commented, Hamutal Yitzhak, CEO of Else Nutrition. "Most notably, our toddler and kids products continue to gain traction as we add major retailers across North America. Specifically, we added several key accounts in the last few months, including Wegmans, HEB, Meijer, and 600 new Walmart U.S. stores, started selling our new Kids RTD line at Loblaws, Giant and Metro, and added Walmart's Canadian website, Walmart.ca. As a result, our revenue increased 23% to $2.6 million in the second quarter of 2024 and we achieved 88% and 111% sequential retail sales growth in the U.S. and Canada, respectively. We believe these results are a strong validation of the market demand for nutritious and healthy alternatives."
"We are also gaining traction in the market with our kids ready-to-drink (RTD) products, demonstrating its broad appeal. Since the launch, we have observed a rapid increase in sales, reflecting strong consumer demand and positive reception. The positive reviews and testimonials further attest to its quality and taste, enhancing our brand's reputation. In fact, our RTD products earned the prestigious Mom's Choice Award. The impressive market performance we are witnessing positions us for future growth and expansion."
"In addition, we recently announced that the Navy Exchange Service Command, or NEXCOM, has listed our full product line. The Navy Exchange offers a variety of goods and services to active military personnel, retirees, and certain civilians on Navy installations in the United States, overseas Navy bases, and aboard Navy ships. We are pleased to report that we have delivered the first shipment of our full range of products to NEXCOM's retail stores. We believe this agreement will serve as a foothold into broader military channels, providing those who serve and their families access to high-quality, nutritious options."
"Furthermore, during the first half of 2024, we moved our U.S. powder production to a new plant, cutting production cost by almost half, and moved to a new packaging partner that reduced our packaging costs and improved our product shelf-life. Over the next several months we plan to add another powder production and packaging facility in Europe that will offer additional cost savings and quality improvements. "
"Overall, we are committed to growing our revenue and capturing a significant share of this multi-billion market, while progressing towards profitability and driving value for our shareholders," concluded Ms. Yitzhak.
2024 Second Quarter Financial Results
All figures are in CAD unless otherwise indicated.
-- Revenue for Q2 2024 increased approximately 10% to $2.60 million compared
to $2.37 million for the same period last year. Revenue for Q2 2024
increased 23% sequentially to $2.6 million compared to Q1 2024.
-- Operating expenses for Q2 2024 decreased 19% to $3.4 million compared to
$4.2 million in Q2 2023.
-- Gross profit in Q2 2024 increased to $263 thousand, or 10% of revenue,
compared to a gross loss of $50 thousand or (-2%) of revenue in Q2 2023.
-- Cash balance as of June 30, 2024, was $1.4 million (including restricted
cash). Subsequent to the quarter, the Company raised US$2 million.
Conference Call
Else Nutrition management plans to host a business update conference call at 10:00 a.m. Eastern Time today to discuss the Company's financial results for the 2024 second quarter ended June 30, 2024, as well as the Company's corporate progress and other developments.
The conference call will be available via telephone by dialing toll free 1-877-704-4453 for U.S. callers or +1-201-389-0920 for international callers. A webcast of the call may be accessed at https://viavid.webcasts.com/starthere.jsp?ei=1682281&tp_key=2832279e6a or on the Investor Relations section of the Company's website at https://investors.elsenutrition.com/.
A webcast replay will be available on the Investor Relations section of the Company's website (https://investors.elsenutrition.com/), through August 14, 2025. A telephone replay of the call will be available approximately three hours following the call, through August 21, 2024, and can be accessed by dialing 1-844-512-2921 for U.S. callers or +1-412-317-6671 for international callers and entering conference ID: 13748206.
To delve deeper into Else Nutrition's offerings and its revolutionary approach to kids' nutrition, visit www.elsenutrition.com
About Else Nutrition Holdings Inc.
Else Nutrition Holdings Inc. (TSX: BABY, OTCQX: BABYF, FSE: 0YL) is a food and nutrition company in the international expansion stage focused on developing innovative, clean, and plant-based food and nutrition products for infants, toddlers, children, and adults. Its revolutionary, plant-based, non-soy formula is a clean-ingredient alternative to dairy-based formulas. Since launching its Plant-Based Complete Nutrition for Toddlers, made of whole foods, almonds, buckwheat, and tapioca, the brand has received thousands of powerful testimonials and reviews from parents, gained national retailer support, and achieved rapid sales growth.
Awards and Recognition:
-- "2017 Best Health and Diet Solutions" award at Milan's Global Food
Innovation Summit
-- #1 Best Seller on Amazon in the Fall of 2020 in the New Baby & Toddler
Formula Category
-- "Best Dairy Alternative" Award 2021 at World Plant-Based Expo
-- Nexty Award Finalist at Expo West 2022 in the Plant-Based lifestyle
category
-- During September 2022, Else Super Cereal reached the #1 Best Seller in
Baby Cereal across all brands on Amazon
-- In May 2024 Else Nutrition's Ready-to-Drink Kids Vanilla Shake Named
Among the Best in Family-Friendly Products by the Prestigious Mom's
Choice Awards(R)
TSX
Neither the TSX nor its regulation services provider (as that term is defined in the policies of the TSX) accept responsibility for the adequacy or accuracy of this release.
Caution Regarding Forward-Looking Statements
This press release contains statements that may constitute "forward-looking statements" within the meaning of applicable securities legislation. Forward-looking statements are typically identified by words such as "will" or similar expressions. Forward-looking statements in this press release include statements with respect to the anticipated dates for filing the company's financial disclosure documents. Such forward-looking statements reflect current estimates, beliefs, and assumptions, which are based on management's perception of current conditions and expected future developments, as well as other factors management believes are appropriate in the circumstances. No assurance can be given that the foregoing will prove to be correct. Forward-looking statements made in this press release assume, among others, the expectation that there will be no interruptions or supply chain failures as a result of COVID-19 and that the manufacturing, broker, and supply logistic agreement with the company does not terminate. Actual results may differ from the estimates, beliefs, and assumptions expressed or implied in the forward-looking statements. Readers are cautioned not to place undue reliance on any forward-looking statements, which reflect management's expectations only as of the date of this press release. The company disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law.
View original content to download multimedia:https://www.prnewswire.com/news-releases/else-nutrition-reports-2024-second-quarter-financial-results-and-provides-business-update-302221842.html
SOURCE Else Nutrition Holdings Inc.
View original content to download multimedia: http://www.newswire.ca/en/releases/archive/August2024/14/c6375.html
/CONTACT:
Investor Relations Contact: Alexandra Schilt, Crescendo Communications, LLC, Office: (212) 671-1020, Email: baby@crescendo-ir.com
Copyright CNW Group 2024
> Dow Jones Newswires
August 14, 2024 07:00 ET (11:00 GMT)
volume today about 1/2 average. patiently waiting for one of those million share days
Volume
112,915
Average Volume (10 days)
243,043
Number of Floating Shares 32.3 M
Short Interest as % of Float 1.34%
I wish we could get a legit #
Exercise of options & Sales:
Interesting to note they all sold @ $4.54 on the same day (8/5). Did anyone notice a huge sale on 8/5, or did the company "buy the shares" on the buyback program?
Insider Activity
Ownership
Insider Activity
Show All Types of Transactions
3 Months
6 Months
1 Year
Weekly Insider Transactions Award of Options Exercise of Options Planned Sale Purchase Sale Stock Gift
Mouseover chart for more detail
Insider Sentiment
MINA BRUCE A. purchased a total of 1,206 shares on May 14, 2024. Presumably, insiders expect the stock price increase to continue. Over the last 3 years insiders have on average purchased 8,333 shares each year.
Insider Transaction History
Date Name-Position Transaction Shares Price Range ($) Shares Held Mkt Value
8/5/24 Newcomer Mark
Chief Executive Officer Sale 69,593 4.54 – 4.54 9,548,886 $316.0 K
Herman Joan M.
Officer and Director Sale 15,854 4.54 – 4.54 799,743 $72.0 K
Strobo Robert
Officer Sale 29,690 4.54 – 4.54 209,811 $134.8 K
Lanford Matthew Lou...
Officer and Director Sale 29,340 4.54 – 4.54 135,091 $133.2 K
Baker Jeffery Bradf...
Chief Financial Officer Sale 34,032 4.54 – 4.54 187,065 $154.5 K
7/31/24 Newcomer Mark
Chief Executive Officer Exercise of Options 150,000 -- – -- 9,618,479 $--
Herman Joan M.
Officer and Director Exercise of Options 36,000 -- – -- 815,597 $--
Strobo Robert
Officer Exercise of Options 64,000 -- – -- 239,501 $--
Lanford Matthew Lou...
Officer and Director Exercise of Options 64,000 -- – -- 164,431 $--
Baker Jeffery Bradf...
Chief Financial Officer Exercise of Options 64,000 -- – -- 221,097 $-
Getting exposure (twice)
Paysign, Inc. to Participate in the August 2024 Sidoti Micro-Cap Virtual Conference
4:15 PM ET 8/8/24 | BusinessWire
Related Quotes
4:00 PM ET 8/9/24
Symbol Last % Chg
PAYS
4.55 -0.55%
Real time quote.
HENDERSON, Nev.--(BUSINESS WIRE)--August 08, 2024--
Paysign, Inc. (NASDAQ: PAYS), a leading provider of prepaid card programs, comprehensive patient affordability offerings, digital banking services, and integrated payment processing, today announced their participation in the Sidoti Micro-Cap Virtual Conference, taking place August 14-15, 2024. Jeff Baker, Paysign's Chief Financial Officer, will be available for one-on-one and small group meetings with investors during the event.
Paysign is scheduled for a group presentation on Wednesday, August 14, at 4:00 p.m. EDT.
To register or learn more about the conference, investors may visit the event website or visit the webinar registration page to attend the live group presentation.
Forward-Looking Statements
Certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933 and Rule 3b-6 under the Securities Exchange Act of 1934 and are subject to the safe harbor created by those rules. All statements, other than statements of fact, included in this release, including, without limitation, statements regarding potential future plans and objectives of the companies, are forward-looking statements that involve risks and uncertainties. There is no assurance that such statements will prove to be accurate, and actual results and future events could differ materially. Paysign undertakes no obligation to publicly update or revise any statements in this release, whether as a result of new information, future events or otherwise.
Paysign, Inc. to Present at the Oppenheimer Technology, Internet & Communications Conference
4:15 PM ET 8/7/24 | BusinessWire
Related Quotes
4:00 PM ET 8/9/24
Symbol Last % Chg
PAYS
4.55 -0.55%
Real time quote.
HENDERSON, Nev.--(BUSINESS WIRE)--August 07, 2024--
Paysign, Inc. (NASDAQ: PAYS), a leading provider of prepaid card programs, comprehensive patient affordability offerings, digital banking services and integrated payment processing, today announced they will be presenting at the Oppenheimer 27(th) Annual Technology, Internet & Communications Conference to be held August 12-14, 2024, through a virtual format.
The focus of the virtual conference is to provide an expansive look across the dynamic sector of the world economy at existing and emerging technologies and provide potential investors the opportunity to evaluate public companies at the forefront of these technological innovations.
Paysign's Chief Financial Officer, Jeff Baker, is scheduled to present on Tuesday, August 13, at 3:45 p.m. EDT.
Investors may learn more about the conference here.
Forward-Looking Statements
Certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933 and Rule 3b-6 under the Securities Exchange Act of 1934 and are subject to the safe harbor created by those rules. All statements, other than statements of fact, included in this release, including, without limitation, statements regarding potential future plans and objectives of the companies, are forward-looking statements that involve risks and uncertainties. There is no assurance that such statements will prove to be accurate, and actual results and future events could differ materially. Paysign undertakes no obligation to publicly update or revise any statements in this release, whether as a result of new information, future events or otherwise.
About Paysign
Paysign, Inc. is a leading provider of prepaid card programs, comprehensive patient affordability offerings, digital banking services and integrated payment processing designed for businesses, consumers and government institutions. Incorporated in 1995 and headquartered in southern Nevada, the company creates customized, innovative payment solutions for clients across all industries, including pharmaceutical, healthcare, hospitality and retail. Built on the foundation of a reliable payments platform, Paysign's end-to-end technologies securely enable digital payout solutions and facilitate the distribution of funds for donor compensation, copay assistance, customer incentives, employee rewards, travel expenses and per diem, reimbursements, gift cards, rebates, and countless other exchanges of value. Paysign's solutions lower costs, streamline operations and improve customer, employee and partner loyalty. To learn more, visit paysign.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240807446992/en/
CONTACT: Investor Relations
ir@paysign.com
888.522.4853
paysign.com/investors
Media Relations
Alicia Ches
888.522.4850
pr@paysign.com
SOURCE: Paysign, Inc.
Copyright Business Wire 2024
> Dow Jones Newswires
August 07, 2024 16:15 ET (20:15 GMT)
I can't keep my hands off $2.50 calls.
the short sellers have backed off a bit today.
Somebody is willing to buy some:
Bid x Size
$0.0861 x 264,239
Ask x Size
$0.09 x 30,000
Real Time Equity Quote: Aug 8, 2024, 2:27 PM ETinfo_outline
Am I correct in assuming this is good for pays?
Flipp'in a few for exercise today.
(PR) Else Nutrition Schedules Second Quarter 2024 Business Update Conference Call
9:00 AM ET 8/6/24 | PR Newswire
Else Nutrition Schedules Second Quarter 2024 Business Update Conference Call
PR Newswire
VANCOUVER, BC, Aug. 6, 2024
VANCOUVER, BC, Aug. 6, 2024 /PRNewswire/ - ELSE NUTRITION HOLDINGS INC. (TSX: BABY) (OTCQX: BABYF) (FSE: 0YL.F) ("Else" or the "Company"), today announced that it plans to host a business update conference call at 10:00 a.m. Eastern Time on August 14, 2024 to discuss the Company's financial results for the 2024 second quarter ended June 30, 2024, as well as the Company's corporate progress and other developments.
The conference call will be available via telephone by dialing toll free 1-877-704-4453 for U.S. callers or +1-201-389-0920 for international callers. A webcast of the call may be accessed at https://viavid.webcasts.com/starthere.jsp?ei=1682281&tp_key=2832279e6a or on the Investor Relations section of the Company's website at https://investors.elsenutrition.com/.
A webcast replay will be available on the Investor Relations section of the Company's website (https://investors.elsenutrition.com/), through August 14, 2025. A telephone replay of the call will be available approximately three hours following the call, through August 21, 2024, and can be accessed by dialing 1-844-512-2921 for U.S. callers or +1-412-317-6671 for international callers and entering conference ID: 13748206.
To delve deeper into Else Nutrition's offerings and its revolutionary approach to kids' nutrition, visit www.elsenutrition.com.
About Else Nutrition Holdings Inc.
Else Nutrition Holdings Inc. (TSX: BABY, OTCQX: BABYF, FSE: 0YL) is a food and nutrition company in the international expansion stage focused on developing innovative, clean, and plant-based food and nutrition products for infants, toddlers, children, and adults. Its revolutionary, plant-based, non-soy formula is a clean-ingredient alternative to dairy-based formulas. Since launching its Plant-Based Complete Nutrition for Toddlers, made of whole foods, almonds, buckwheat, and tapioca, the brand has received thousands of powerful testimonials and reviews from parents, gained national retailer support, and achieved rapid sales growth.
Awards and Recognition:
-- "2017 Best Health and Diet Solutions" award at Milan's Global Food
Innovation Summit
-- #1 Best Seller on Amazon in the Fall of 2020 in the New Baby & Toddler
Formula Category
-- "Best Dairy Alternative" Award 2021 at World Plant-Based Expo
-- Nexty Award Finalist at Expo West 2022 in the Plant-Based lifestyle
category
-- During September 2022, Else Super Cereal reached the #1 Best Seller in
Baby Cereal across all brands on Amazon
TSX
Neither the TSX nor its regulation services provider (as that term is defined in the policies of the TSX) accept responsibility for the adequacy or accuracy of this release.
Caution Regarding Forward-Looking Statements
This press release contains statements that may constitute "forward-looking statements" within the meaning of applicable securities legislation. Forward-looking statements are typically identified by words such as "will" or similar expressions. Forward-looking statements in this press release include statements with respect to the anticipated dates for filing the company's financial disclosure documents. Such forward-looking statements reflect current estimates, beliefs, and assumptions, which are based on management's perception of current conditions and expected future developments, as well as other factors management believes are appropriate in the circumstances. No assurance can be given that the foregoing will prove to be correct. Forward-looking statements made in this press release assume, among others, the expectation that there will be no interruptions or supply chain failures as a result of COVID-19 and that the manufacturing, broker, and supply logistic agreement with the company does not terminate. Actual results may differ from the estimates, beliefs, and assumptions expressed or implied in the forward-looking statements. Readers are cautioned not to place undue reliance on any forward-looking statements, which reflect management's expectations only as of the date of this press release. The company disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law.
View original content to download multimedia:https://www.prnewswire.com/news-releases/else-nutrition-schedules-second-quarter-2024-business-update-conference-call-302215239.html
SOURCE Else Nutrition Holdings Inc.
/CONTACT: Investor Relations Contact: Alexandra Schilt, Crescendo Communications, LLC, Office: (212) 671-1020, Email: baby@crescendo-ir.com
> Dow Jones Newswires
August 06, 2024 09:00 ET (13:00 GMT)
John Hickman leapfrogs Gary P. (-;
"Jon Hickman
Ladenburg Thalmann & Co.
Buy
08/02/24 $7.25"
Grabbed a few cheepies, flipped 'em, Have way more than I need.
Today we got the volume explosion I've been anticipating>IN THE WRONG DIRECTION:
Volume
500,241
Average Volume (10 days)
176,058
shortie having a field day. Didn't think it would be in the cards.
REMINDER TO HOLD SHARES TIGHTLY:
- Added eight net new patient affordability programs during second
quarter 2024, exiting the quarter with 61 active programs, leading to a
266.8% increase in pharma patient affordability revenue over the same
period last year
WOW, if pps hits $7.50 by 11/20 I'll lose a bunch but will have plenty left.
PA ALL THE WAY!
Added eight net new patient affordability programs during second quarter
2024, exiting the quarter with 61 active programs, leading to a 266.8%
increase in pharma patient affordability revenue over the same period
last year.
KICK'IN AZZ!
Second quarter 2024 patient affordability claim volume increased 365.5%,
versus second quarter 2023
Paysign, Inc. Reports Second Quarter 2024 Financial Results
4:02 PM ET 7/31/24 | BusinessWire
Related Quotes
4:00 PM ET 7/31/24
Symbol Last % Chg
PAYS
5.33 2.11%
Real time quote.
-- Second quarter 2024 total revenues of $14.33 million, up 29.8% from
second quarter 2023
-- Second quarter 2024 net income of $697 thousand, or diluted earnings per
share of $0.01, versus net loss of $104 thousand, or diluted earnings per
share of $(0.00) for second quarter 2023
-- Second quarter 2024 Adjusted EBITDA of $2.24 million, up 95.8% from $1.14
million for second quarter 2023, while diluted Adjusted EBITDA per share
was $0.04 versus $0.02 for second quarter 20231
-- Total plasma center count increased by eight net new centers during
second quarter 2024, exiting the quarter with 477 centers, contributing
to a 12.6% increase in plasma revenue versus the same period last year
-- Added eight net new patient affordability programs during second quarter
2024, exiting the quarter with 61 active programs, leading to a 266.8%
increase in pharma patient affordability revenue over the same period
last year
-- Exited the quarter with $31.29 million of unrestricted cash and zero
debt; $22.71 million related to payment timing on pass-through claim
reimbursement receivables and related payables
-- Second quarter 2024 gross dollar load volume was up 12.7% compared to
second quarter 2023
-- Second quarter 2024 gross spend volume was up 11.2% compared to second
quarter 2023
-- Second quarter 2024 average revenue per plasma center per month of
$7,916, up 4.4%, versus $7,581 for second quarter 2023
-- Second quarter 2024 patient affordability claim volume increased 365.5%,
versus second quarter 2023
Just grabbed a few (100) March $2.50's for $3.10 (=$5.60)
Volume
47,143
Average Volume (10 days)
184,096
What will happen when volume explodes?
(joke question)
I'm beginning to think FDA approval is just a pipe dream.
From time to time I check to see if anything new:
Shareholder Equity
Shares Outstanding 53.0 M
Institutional Ownership 26.79%
Number of Floating Shares 32.5 M
Short Interest as % of Float 1.42
If mgmt owns a large % of float, "real float" is quite small.
I thought we would be strong Mon, Tues & Wed. WRONGO!
Am I delusional thinking a great Q is in the cards?
If anyone cares:
Else Nutrition With Partnership Expansion Announcement
7:59 AM ET 7/30/24 | MT Newswires
Else Nutrition With Partnership Expansion Announcement
07:59 AM EDT, 07/30/2024 (MT Newswires) -- Else Nutrition Holdings (BABY.TO), which saw its shares jump 8.7% from near 52 week lows yesterday, on Tuesday announced its expanded partnership with Walmart, involving the launch of its entire product line on the superstore's Canadian online store in August 2024.
Canadian consumers will be able to purchase Else Nutrition's full range of products, including Toddler Nutrition, Kids Shakes, Ready-To-Drink (RTD) nutrition shakes and cereals, directly through the online platform of the retailer, which has 403 stores nationwide.
The retailer's Canadian division serves 1.5 million customers each day and hosts more than 1.5 million daily visits to the Canadian e-store.
MrD, PA is now in the drivers seat. We don't have long to wait: TUESDAY!!!
Volume so far today tiny:
Volume
13,985
Average Volume (10 days)
349,579
Longs holding tight, shorts standing pat.
Monday & Tuesday might display fireworks.
If pps breaks $7.50 by DECEMBER, I'll be out. With an extremely healthy boat load of cash
jp, hope you took advantage of early morning bargains.
jp, hope you took advantage of early morning bargains.
You may be able to harvest some tomorrow . When they sell PAYS down, it usually lasts a few days.
WOW, the 4 of us will be on the collecting end.
I'm also grabbing some $2.50 calls and selling $7.50's
always happens:
make new high, selloff next day.
Arrgh
waiting 1 week from today.
grabbed some 13's, 14's & 15's.
New high today
GLTY!
I don't think BABY will go belly up but prospects don't look very encouraging.
We might have some shorts caught by the short hairs
Volume
81,678
Average Volume (10 days)
172,258
Waiting patiently for volume explosion.
Pbly the week starting July 22.
Been waiting for this:
Volume
157,165
Average Volume (10 days)169,988
broke above EMA ($4.04) today
still below 50 day MA (4.37)
This never changes, so I don't believe it. Wish I knew the real #.
Number of Floating Shares 32.5 M
Short Interest as % of Float 1.42%